CLINICAL_TRIALS
trial_result
· 2010-10-11
Clinical Trial Update: Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) [Phase 2]
Summary
Phase 2 trial update for immunotherapy in men with metastatic androgen independent prostate cancer (D9902 Part B).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dendreon | Conditions: Metastatic Androgen Independent Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2010-10-11